info@buecher-doppler.ch
056 222 53 47
Warenkorb
Ihr Warenkorb ist leer.
Gesamt
0,00 CHF
  • Start
  • Cardiovascular Medicine: New Therapeutic Drugs Approved by the US FDA (2013-2017)

Cardiovascular Medicine: New Therapeutic Drugs Approved by the US FDA (2013-2017)

Angebote / Angebote:

Written in an accessible style and consistent format, "Cardiovascular Medicine: New Therapeutic Drugs Approved by the US FDA (2013-2017)" takes a unique approach to integrating the fundamental concepts with high quality cutting-edge research discoveries and translating essential bioscience to evidence-based clinical medicine so as to provide the reader a comprehensive picture of this rapidly evolving field in a concise manner. Blends basic and clinical sciences needed to effectively demonstrate the importance of the field Includes full-color illustrations to facilitate the understanding of the essential concepts Cites references mostly from highly influential journals to ensure the top quality of the information Uses chapter highlights and self-assessment questions to enhance the assimilation of the cutting-edge knowledge Serves as a valuable reference or textbook for students, faculty, clinician, and other health professionals in the fields of biomedical science, pharmacology, pharmacotherapeutics, and clinical medicine
Folgt in ca. 15 Arbeitstagen

Preis

177,00 CHF

Artikel, die Sie kürzlich angesehen haben